Inflammatory
-
Several new studies are reporting evidence affirming a growing hypothesis that links inflammation with the cognitive deficits seen in bipolar disorder and Alzheimer’s. It's also suggested low-grade inflammation can result in mental sluggishness.
-
A new metastudy is suggesting anti-inflammatory drugs can reduce symptoms of depression, affirming the long-suspected link between neuroinflammation and depression. However, another study is claiming there is no causal link between the two factors.
-
Early clinical trial results are suggesting a novel drug designed to inhibit the activity of a key immune signaling molecule could become a promising new treatment for atopic dermatitis, a very common inflammatory skin condition.
-
New research has for the first time demonstrated how exposure to Narrow Band Ultraviolet B light (UVB) can directly influence gut microbiome diversity in humans. The research hypothesizes this result is modulated by vitamin D.
-
First results have been revealed from phase 2 human trials into a promising new treatment for celiac disease. The nanoparticle technology was found to significantly induce an immune tolerance to gluten in celiac subjects after just two treatments.
-
New research has identified a specific genetic variant that may act as a biomarker for patients that are unlikely to respond to new biologic treatments for Crohn's disease.
-
New research reveals different types of fasting results in significantly different immune responses.
-
New research demonstrates how a high-fat diet can disrupt levels of an intestinal immune cell known to help regulate microbial populations in the gut. The study shows how low-levels of this molecule result in increased growth of harmful gut bacteria, leading to inflammation and insulin resistance.
-
A new study is suggesting vibration therapy can beneficially alter the gut microbiome, and reduce diabetes-related inflammation. The research at this point has only been verified in mice, and prior human vibration therapy studies suggest these results may not broadly translate to human treatments.
-
A team of researchers in Poland has proposed a novel, non-invasive test for screening and monitoring gut diseases such as Crohn’s disease and ulcerative colitis. The technique uses a tiny blood / stool sample to determine gut permeability, a key marker of these diseases.
-
Research led by the University of Arizona may have uncovered a new potential treatment target for tinnitus – not the ears but within the brain itself. The study suggests that neuroinflammation is to blame, and could be a new way to fix the problem.
-
Two new research papers are shedding light on the fascinating relationship between inflammation and behavior, suggesting our immune system can play a significant role in both our motivation and decision-making abilities.